Description
PRESSCAND is indicated for:
· Treatment of primary hypertension in adults.
· Treatment of hypertension in children and adolescents aged 6 to < 18 years.
· Treatment in adults of heart failure with left ventricular systolic dysfunction (left ventricular ejection fraction = 40%):
* in case of intolerance to angiotensin converting enzyme (ACE) inhibitors
* in case of intolerance to aldosterone antagonists, as add-on therapy to ACE inhibitor therapy in symptomatic patients despite optimal therapy,